Skip to content

Techcyte Secures $15 Million in Funding Led by Van Tuyl Companies

Techcyte, a leader in AI-powered digital diagnostics for anatomic and clinical pathology, has successfully raised $15 million, primarily from Van Tuyl Companies, to bolster its growth and profitability strategies. The company currently enjoys profitability in its veterinary sector.

OREM, Utah–(BUSINESS WIRE)– #AIinHealthcare–Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced the completion of a $15 million capital raise led by Van Tuyl Companies, with participation from existing investors Zoetis Inc. (“Zoetis”) and Mayo Clinic. This funding reinforces Techcyte’s ability to execute on its strategic priorities and supports its path to profitability. Techcyte’s veterinary business is currently profitable, and the company expe